Cargando…
Proton pump inhibitors versus H2 antagonists for prevention of COVID-19 complications
Autores principales: | Kishore, E, Singh, V, Dihowm, F |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Southern Society for Clinical Investigation. Published by Elsevier Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9883784/ http://dx.doi.org/10.1016/S0002-9629(23)00651-1 |
Ejemplares similares
-
I-48 The clinical characteristics and therapy for SARS
por: Guo, L.M.
Publicado: (2008) -
CS14-04 The Development of an AIDS Mucosal Vaccine
por: Chen, Zhiwei
Publicado: (2009) -
Coronavirus at the heart center of Puerto Rico (hispanic country) incidence-death: the importance of the reduction of myocardial disease due to protective genes
por: Colón, FJ, et al.
Publicado: (2023) -
COVID-19 related mortality in texas border counties versus non-border counties
por: Obaid, A., et al.
Publicado: (2023) -
Coenzyme Q(10) prevents hepatic fibrosis, inflammation, and oxidative stress in a male rat model of poor maternal nutrition and accelerated postnatal growth(1)
por: Tarry-Adkins, Jane L, et al.
Publicado: (2016)